Showing 1561-1570 of 7001 results for "".
When Movements Steal Lives: TD Burden, Stigma, and the Therapeutic Alliance
https://reachmd.com/programs/cme/when-movements-steal-lives-td-burden-stigma-and-the-therapeutic-alliance/56641/Improve your diagnostic and screening skills for tardive dyskinesia and learn about the important role of VMAT2 inhibitors in the management of this disorder.DWTV Extra: Skin and Scalp Health
https://reachmd.com/series/dermwire-tv/dwtv-extra-skin-and-scalp-health/54147/Chesahna Kindred, MD, MBA, FAAD, discusses an event at the Science of Skin & Scalp Studio in New York, New York, featuring interactive rooms led by dermatologists, beauty experts, and influencers living with chronic inflammatory conditions sharing stories and shaping the conversation around skinEmergencies at 30,000 Feet: Ground Support
https://reachmd.com/programs/clinicians-roundtable/emergencies-at-30000-feet-ground-support-1/1156/You're a healthcare professional and you've just answered the call to help a sick airline passenger while cruising at 30,000 feet. No resources; no support staff; no emergency landing for another 1/2 hour. No problem! You know what to do because you listen to boonDOCS Medicine... Tune in with DrWhat Does It Mean to Be Rich?
https://reachmd.com/programs/your-money-your-life-financial-advice-for-physicians/what-does-it-mean-be-rich/8135/Who is really rich? It is probably not who you think. Join Jim Hemphill, CERTIFIED FINANCIAL PLANNER™ and co-founder of TGS Financial Advisors, as he discusses the benefits of adopting a more practical and functional definition of wealth. Click here to learn more about other financial related prograSublingual Immunotherapy for Peanut Allergy: The Value of Early Intervention
https://reachmd.com/programs/frontlines-food-allergies/sublingual-immunotherapy-for-peanut-allergy-the-value-of-early-intervention/30039/Explore the potential of sublingual immunotherapy as an early intervention for peanut allergies in young children.Time Is Hair: An Update on the Diagnosis and Treatment of Scarring Alopecias in Patients with Darker Skin Tones
https://reachmd.com/programs/practical-dermatology/time-is-hair-an-update-on-the-diagnosis-and-treatment-of-scarring-alopecia-in-patients-with-darker-skin-tones/18198/In part two of a three-part podcast series on dermatologic issues facing patients with darker skin tones, Dr. Andrew Alexis, a dermatologist from New York City and the President of the Skin of Color Society; Dr. Corey Hartman, a dermatologist in Birmingham, Alabama; and Dr. Janiene Luke, a dermatoloInvestment: How a Physician Can Earn Less Than a Waiter
https://reachmd.com/programs/your-money-your-life-financial-advice-for-physicians/investment-how-physician-can-earn-less-waiter/8132/What can a doctor earn as an active investor? Probably way less than you think. Join Jim Hemphill, CERTIFIED FINANCIAL PLANNER™ and co-founder of TGS Financial Advisors, as he calculates how investment activity translates into compensation per hour. Click here to learn more about other financial relClosing the Gap: Equity, Disparities, and Access to TD Diagnosis and Care
https://reachmd.com/programs/cme/closing-the-gap-equity-disparities-and-access-to-td-diagnosis-and-care/56644/Improve your diagnostic and screening skills for tardive dyskinesia and learn about the important role of VMAT2 inhibitors in the management of this disorder.From “EPS” to Personalized TD Treatment: Matching VMAT2 MOA to the Patient
https://reachmd.com/programs/cme/from-eps-to-personalized-td-treatment-matching-vmat2-moa-to-the-patient/56646/Improve your diagnostic and screening skills for tardive dyskinesia and learn about the important role of VMAT2 inhibitors in the management of this disorder.Psychiatric Comorbidity in Epilepsy: New Evidence from AES 2025
https://reachmd.com/programs/practical-neurology/psychiatric-comorbidity-in-epilepsy-new-evidence-from-aes-2025/39914/Ali Rafati, MD, MPH, Johns Hopkins Medicine, Baltimore, MD, and Churl-Su Kwon, MD, MPH, Columbia University Irving Medical Center, New York, NY, present new data from AES 2025 which reveal how depression and epilepsy are bidirectionally linked—and why neurologists must rethink screening and early in